Operating Margin: Operating margin measurement of what proportion of a company's revenue is left over after paying for variable costs of production such as wages, raw materials, etc. Calculated as: Operating Income / Total Revenues
Radiopharm Theranostics Limited - Sponsored ADR (RADX) had Operating Margin of -1050.63% for the most recently reported fiscal year, ending 2025-06-30.
| Income Statement Financials | |
$2.35M |
|
$-24.83M |
|
$2.33M |
|
$0.03M |
|
$27.07M |
|
$-24.72M |
|
$-0.04M |
|
$-24.76M |
|
$-24.76M |
|
$-24.83M |
|
$-24.83M |
|
$-24.83M |
|
$-24.83M |
|
$-24.72M |
|
$-23.04M |
|
6.94M |
|
6.94M |
|
$-3.42 |
|
$-3.42 |
|
| Balance Sheet Financials | |
$25.81M |
|
$0.03M |
|
$30.20M |
|
$56.01M |
|
$9.67M |
|
-- |
|
$18.57M |
|
$28.24M |
|
$27.76M |
|
$-2.40M |
|
$27.76M |
|
7.88M |
|
| Cash Flow Statement Financials | |
$-23.73M |
|
$1.15M |
|
$29.42M |
|
$12.03M |
|
$18.86M |
|
$6.83M |
|
$1.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
1.08% |
|
|
Operating Margin |
-1050.63% |
-1050.63% |
|
-979.19% |
|
-1052.43% |
|
-1055.27% |
|
$-23.73M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
0.35 |
|
1044.75 |
|
-89.43% |
|
1035.58% |
|
-44.34% |
|
-89.43% |
|
$3.52 |
|
$-3.42 |
|
$-3.42 |
|